Roche wards off Herceptin copycats with new, easy-to-use Perjeta combo product chelfand Tue, 06/30/2020 – 11:49 More: Roche wards off Herceptin copycats with new, easy-to-use Perjeta combo product Source: fierce
read moreWith more nays than yays for Gilead’s remdesivir pricing, are pharma’s rep gains sunk? beth.bulik Tue, 06/30/2020 – 10:03 More: With more nays than yays for Gilead's remdesivir pricing, are pharma's rep gains sunk? Source: fierce
read moreGSK’s Duvroq, Akebia’s Vafseo win global first nods in Japan to challenge Astellas’ anemia drug aliu Tue, 06/30/2020 – 09:45 More: GSK's Duvroq, Akebia's Vafseo win global first nods in Japan to challenge Astellas' anemia drug Source: fierce
read moreFDA will require 50% efficacy for COVID-19 vaccines, WSJ says. How high is that bar? esagonowsky Tue, 06/30/2020 – 09:20 More: FDA will require 50% efficacy for COVID-19 vaccines, WSJ says. How high is that bar? Source: fierce
read moreThe funds will enable in-house drug discovery across a number of therapeutic areas including cancer and neurodegeneration More: Cambridge spin-out PharmEnable raises £1.8m for drug discovery Source: News
read moreMerck’s Keytruda lands new colorectal cancer nod, its 2nd biomarker-based OK this month chelfand Tue, 06/30/2020 – 04:00 More: Merck's Keytruda lands new colorectal cancer nod, its 2nd biomarker-based OK this month Source: fierce
read more© 1994 - 2024 B.M. Pharmaceuticals